
Insulin Lispro (Humalog)
Medication
- Sendes fra Tyskland
Bestilling
- DHL med sporing
- Diskret emballage
Kort fortalt
Insulin Lispro (Humalog) i tal
Nøgletallene fra vores leksikon.
Hele leksikonopslaget- Class
- Rapid-acting insulin analogue
- Sizes
- 6ml/600iu1 size in the shop
What studies show
All 5 sources in the lexicon- Howey et al., Diabetes, 1994
- Anderson et al., Diabetes, 1997
- Brunelle et al., Diabetes Care, 1998
Anmeldelser
Hvad kunderne siger
Kun rigtige bestillinger, der indeholdt Insulin Lispro (Humalog).
Alle anmeldelserDer er endnu ingen laboratorieanalyse for Insulin Lispro (Humalog). Stem på denAlle laboratorieanalyser
Viden
Alt om Insulin Lispro (Humalog)
Detaljerede oplysninger kommer snart.
How does Insulin Lispro differ from regular insulin?
Two building blocks at positions B28 and B29 are swapped. The molecules therefore cluster much less and pass from the depot into the blood faster. In 10 healthy men the peak level came after 42 instead of 101 minutes and was more than twice as high. At the receptor Lispro acts like human insulin.
Is Insulin Lispro approved?
Yes. ChEMBL lists Insulin Lispro as an approved drug with first approval in 1996. On ClinicalTrials.gov more than 350 trials list Insulin Lispro among their interventions (as of 25 October 2026). Everything here is the state of research, not a recommendation.
What did the trial on injection timing show?
The trial varied the gap between injection and meal. The best control came with Lispro on average 22.5 minutes before eating, with regular insulin 63.8 minutes before. The lowest mean blood sugar was practically the same, the swings after eating were smaller with Lispro.
How often did hypoglycaemia occur?
In 1,008 patients with type 1 diabetes hypoglycaemia was 12 percent less frequent with Lispro than with regular insulin, most clearly at night. Across eight trials with more than 1,400 patient-years 3.1 percent had severe hypoglycaemia with Lispro versus 4.4 percent with regular insulin.
Does Lispro replace a basal insulin?
No, it complements it. In a trial with 66 patients over 5 months the basal insulin was adjusted as well after switching to Lispro, from 1.4 to 3.1 NPH injections a day on average. HbA1c fell from 8.8 to 8.0 percent and hypoglycaemia did not increase. The authors see the right basal insulin as the key.
What is the biggest risk?
Hypoglycaemia, a direct consequence of the main effect. The action window is short and steep, a skipped meal falls right into the peak. Even in the trials with diabetes and medical supervision a few percent of patients had severe hypoglycaemia.
Relateret
Relaterede produkter
Telmisartan
Medicin · Hjerte-kar Hjerte-kar
2 størrelser
Laboratorietestet
Ivermectin
Medicin · Mave og lever Mave og lever
1 størrelse
Fenbendazol
Medicin · Mave og lever Mave og lever
1 størrelse
Prednisone
Medicin · Mave og lever Mave og lever
1 størrelse
Insulin Lispro (Humalog)